🇺🇸 Skin test panel and desensitization kit in United States

FDA authorised Skin test panel and desensitization kit on 12 June 1941

Marketing authorisations

FDA — authorised 12 June 1941

  • Application: NDA003977
  • Marketing authorisation holder: PARKEDALE
  • Local brand name: THEELIN
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 21 February 1979

  • Application: ANDA085239
  • Marketing authorisation holder: DR REDDYS
  • Local brand name: ESTRONE
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA

  • Application: ANDA083397
  • Marketing authorisation holder: WATSON LABS
  • Local brand name: ESTRONE
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA

  • Application: ANDA083488
  • Marketing authorisation holder: WYETH AYERST
  • Local brand name: ESTROGENIC SUBSTANCE
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA

  • Application: ANDA085237
  • Marketing authorisation holder: WATSON LABS
  • Local brand name: NATURAL ESTROGENIC SUBSTANCE-ESTRONE
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

Frequently asked questions

Is Skin test panel and desensitization kit approved in United States?

Yes. FDA authorised it on 12 June 1941; FDA authorised it on 21 February 1979; FDA has authorised it.

Who is the marketing authorisation holder for Skin test panel and desensitization kit in United States?

PARKEDALE holds the US marketing authorisation.